Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Breakthroughs in Non-Alcoholic Steatohepatitis Management” report has been added to ResearchAndMarkets.com’s offering. Non-Alcoholic Steatohepatitis or NASH is a…
Financing to drive leadership in AAV vector-delivered one-time therapies for major chronic pet health conditions Company supported by leading life…
LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated an additional…
Series A financing led by two leading global venture capital firms – Sequoia Capital China and Highlight Capital SAN DIEGO–(BUSINESS…
TOKYO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, announced…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on April 3, 2019 the Compensation Committee of…
Quarterly Revenues Up 15%; Board of Directors Announces Quarterly Dividend of $0.06 Per Share LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq:SLP),…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today…
WASHINGTON–(BUSINESS WIRE)–Today, Citizens Against Government Waste (CAGW) released an analysis of misguided provisions in Gov. Tim Walz’s (D-Minn.) budget that…
SAN ANTONIO–(BUSINESS WIRE)–Recognizing the potential of new technology for enhanced contamination control in cleanrooms where pharmaceuticals are made, RevDesinfectie Robots…